Redefining Autism Care Through Cellular Innovation
Hrvoje Milakovic
In recent years, breakthroughs in regenerative medicine have created new hope for families seeking alternatives to conventional autism treatment. At AMSA Biotech, our focus is on the development and application of biological therapies that not only address behavioral symptoms, but also target underlying neuroinflammatory and immune-related components often associated with autism spectrum disorder (ASD). By integrating advanced cell-based strategies, we are shifting the paradigm of how autism is.